Nonalcoholic fatty liver disease following liver transplantation.
about
Liver transplantation and non-alcoholic fatty liver disease.Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans.
P2860
Nonalcoholic fatty liver disease following liver transplantation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Nonalcoholic fatty liver disease following liver transplantation.
@en
type
label
Nonalcoholic fatty liver disease following liver transplantation.
@en
prefLabel
Nonalcoholic fatty liver disease following liver transplantation.
@en
P2093
P2860
P1476
Nonalcoholic fatty liver disease following liver transplantation.
@en
P2093
Jason M Vanatta
Sanjaya Kumar Satapathy
Satheesh Nair
P2860
P2888
P304
P356
10.1007/S12072-013-9434-3
P577
2013-04-26T00:00:00Z